PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Небольшая подборка полезной литературы

Опубликовано 6 марта, 201930 июня, 2019 frozencat

Data And Safety Monitoring Committees In Clinical Trials

Epidemiology and Biostatistics An Introduction to Clinical Research

Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trials Using R

Clinical trial data analysis with R and SAS

Clinical Trials Design in Operative and Non Operative Invasive Procedures

Analyzing Longitudinal Clinical Trial Data: A Practical Guide

Bioequivalence and Statistics in Clinical Pharmacology, Second Edition

Design and Analysis of Bioavailability and Bioequivalence Studies

Biomaterials in Clinical Practice : Advances in Clinical Research and Medical Devices

Fundamental Statistical Inference A Computational Approach

Statistics and Simulation

Medical biostatistics

Biostatistics

Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development

Biosimilar Clinical Development: Scientific Considerations and New Methodologies

Рубрики: Блог, Общее

Навигация по записям

Предыдущая запись: Расчет доверительных интервалов для 2X2 биоэквивалентности: Julia concept code
Следующая запись: Протокол и отчет клинического исследования биоэквивалентности: шаблон

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20180816 142504
20180131 135955
DJI 0030
20180815 151848
20180202 160114
20180816 150843
  • Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • GAMMAGARD LIQUID
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-30 By FDA
  • Drug Safety Communications
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • Ultra Seal Corporation - 624650 - 09/25/2024
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • Azurity Pharmaceuticals, Inc. - 656489 - 09/20/2024
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • Nomida.biz - 687590 - 09/12/2024
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • Aerosol and Liquid Packaging, Inc. - 676746 - 07/24/2024
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • Accupack Midwest, Inc. - 680228 - 08/15/2024
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • Media Networks Sydney Pty Limited - 687044 - 09/18/2024
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • Biosimilar Product Information
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-30 By FDA
  • Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 55, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-30
  • Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine,tozinameran,riltozinameran and tozinameran,famtozinameran and tozinameran,raxtozinameran, Date of authorisation: 21/12/2020, Revision: 54, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-30
  • Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 32, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-30
  • Human medicines European public assessment report (EPAR): BroPair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 4, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-30
  • Human medicines European public assessment report (EPAR): Levetiracetam Actavis, levetiracetam, Date of authorisation: 03/10/2011, Revision: 20, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-30
Предыдущие записи
Тема: Scaffold от Danny Cooper.